prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
71956,3.26964110000e+16,68985021,286,Safinamide 100mg tablets,Safinamide methansulfonate,100mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,April 2018,68985021,,,,,,,,,0,4090102
71480,3.05385110000e+16,54025021,6,Rasagiline 1mg tablets (Alliance Healthcare (Distribution) Ltd),Rasagiline,1mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,January 2018,54025021,,,,,,,,,0,4090102
7040,418125001,89182020,136513,Rasagiline 1mg tablets,Rasagiline,1mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,February 2009,13170001,,,,,,,,,0,4090102
70138,3.25051110000e+16,68986021,24,Xadago 100mg tablets (Profile Pharma Ltd),Safinamide methansulfonate,100mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,September 2017,68986021,,,,,,,,,0,4090102
21793,9362611000001104,89184020,8862,Azilect 1mg tablets (Teva UK Ltd),Rasagiline,1mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,February 2009,13171001,,,,,,,,,0,4090102
74525,3.25048110000e+16,68988021,6,Xadago 50mg tablets (Profile Pharma Ltd),Safinamide methansulfonate,50mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,January 2019,68988021,,,,,,,,,0,4090102
67100,3.26965110000e+16,68987021,443,Safinamide 50mg tablets,Safinamide methansulfonate,50mg,Tablet,Oral,Monoamine-Oxidase-B Inhibitors,August 2016,68987021,,,,,,,,,0,4090102
